课题基金 / 基金详情

Application of Ninjurin, a novel adhesion molecule, to diagnosis and therapeutics of primary hepatocellular carcinoma

Application of Ninjurin, a novel adhesion molecule, to diagnosis and therapeutics of primary hepatocellular carcinoma
新型粘附分子Ninjurin在原发性肝细胞癌诊断和治疗中的应用
批准号:
11670499
负责人:
SASAKI Yutaka
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

SASAKI Yutaka的其他基金

相似基金

相关文献

中文摘要
翻译
Ninjurin是一种新的蛋白质,在神经损伤后上调。据报道,Ninjurin表现出嗜同性粘附分子的性质,并在神经突起再生中起重要作用。我们发现,在大鼠肝再生模型中,Ninjurin的表达在增殖期后的分化期增强。此外,Ninjurin在人肝癌组织的癌灶中表达降低。为了确定Ninjurin在人肝细胞中表达的生物学后果,我们建立了组成型过表达Ninjurin蛋白的Huh 7,并进行了以下检查:(1)用血细胞计数器分析生长曲线,(2)流式细胞术分析细胞周期,(3)Western blot分析细胞周期相关蛋白。与对照细胞相比,过表达Ninjurin的Huh 7细胞的增殖受到抑制。细胞周期在G1/S期阻滞,S期细胞比例从45%下降到25%。Ninjurin诱导的细胞凋亡阻滞伴随着p21表达水平的升高和Cdk 2、Cdk 4、Cdk 6表达水平的降低。而Cdk抑制因子p16、p27、cyclin D1、Cyclin E的表达无明显变化。相反,Cyclin A的表达略有下降。以这种方式,Ninjurin诱导细胞周期激活剂的下调和细胞周期抑制剂的上调,随后抑制细胞生长。这些观察结果表明,Ninjurin在HCC中的低表达可能有助于肝癌细胞的生长。因此,Ninjurin的诱导有望抑制肝癌的生长,这可能为肝癌的治疗提供一种新的策略。
英文摘要
Ninjurin is a novel protein that is up regulated after nerve injury. It is reported that Ninjurin demonstrates properties of a homophilic adhesion molecule and plays an important role in neurite regeneration. We found that, in rat liver regeneration model, Ninjurin expression was enhanced in the differentiation phase after proliferation phase. In addition, expression of Ninjurin was decreased in cancerous lesion of human hepatocellular carcinoma tissue. To determine the biological consequence of Ninjurin expression in human hepatocytes, we established Huh7 constitutively over-expressing Ninjurin protein and performed the following examinations, (1) analysis of growth curve with hemocytometer, (2) flow cytometric analysis of cell cycle, (3) Western blot analysis of cell cycle related protein. Proliferation of Huh7 cells over-expressing Ninjurin was inhibited compared to that of control cells. Cell cycle was arrested at G1/S checkpoints on a fluorescence-activated cell sorter, and the fraction of S phase declined from 45% to 25%. The arrest induced by Ninjurin was accompanied by the accumulation of p21 expression level and decreases of Cdk2, Cdk4, Cdk6 expression levels. But there is no change in the expression of Cdk inhibitor p16, p27, cyclin D1, and Cyclin E expression. In contrast, expression of Cyclin A was slightly decreased. In this way, Ninjurin induces both down-regulation of cell cycle activators and up-regulation of cell cycle inhibitor, followed by inhibition of cell growth. These observations suggest that the low expression of Ninjurin in HCC may contribute to growth of hepatoma-cells. Therefore, induction of Ninjurin can be expected to suppress growth of hepatoma, which may provide a novel strategy for hepatocellular carcinoma.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tatsumi T.: "B7-1(CD80)-gene transfer combined with interleukin 12 administration elicits protective and therapeutic immunity against mouse hepatocellular carcinoma"Hepatology. 30. 422-429 (1999)
Tatsumi T.:“B7-1(CD80) 基因转移与白细胞介素 12 联合给药可引发针对小鼠肝细胞癌的保护性和治疗性免疫”肝病学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kanto, T., Hayashi, N., Takehara, T., Tatsumi, T., Kuzushita, N., Ito, A., Sasaki, Y., et al.: "Impaired allostimulatory capacity of peripheral blood dendtric cells recovered from hepatitis C virus-infected individuals."J.Immunol.. 162. 5584-5591 (1999)
Kanto, T.、Hayashi, N.、Takehara, T.、Tatsumi, T.、Kuzushita, N.、Ito, A.、Sasaki, Y. 等人:“从细胞中回收的外周血树突状细胞的同种刺激能力受损
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 30 条
    Scholarly Activities of the Social Science Research Council to Construct the Interdisciplinary Knowledge of the Social Sciences
    • 批准号:
      19K01513
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      2019
    • 负责人:
      SASAKI Yutaka
    • 依托单位:
    Investigation of c-ktlow murine hematopoietic stem cells for the role in aged animals
    • 批准号:
      25460483
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2013
    • 负责人:
      SASAKI Yutaka
    • 依托单位:
    NMR of extremely diluted impurity helium-3in quantum solid helium-4
    • 批准号:
      22654039
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.95万
    • 财政年份:
      2010
    • 负责人:
      SASAKI Yutaka
    • 依托单位:
    Development of compounded type Kansei presumption/automated design system and a Kansei communication interface
    • 批准号:
      21780239
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.83万
    • 财政年份:
      2009
    • 负责人:
      SASAKI Yutaka
    • 依托单位:
    海外基金